2025-03-26 03:31:23
Latest Post
Rulka Electricals Secures 21 New Work Orders totaling Rs 12.36 Crore in March 2025
Ambo Agritec Ltd to expand presence in FMCG segment
Prism Johnson Ltd declared preferred bidder for mining lease of limestone block
Welspun Michigan Engineers Secures New Order to Upgrade the Haji Ali Storm Water Pumping Station in Mumbai
Capitalizing on Growth: Why Financial Services Firms Need a Unified AI Strategy
Stock Report
Zim Laboratories Ltd reports Rs. 8.08 crores consolidated net profit in Q4 FY2024
Posted On : 2024-05-14 21:09:39( TIMEZONE : IST )
Zim Laboratories Ltd has reported Consolidated financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 119.3975 crores during the period ended March 31, 2024 as compared to Rs. 97.4049 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. 8.0857 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 4.7846 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. 1.66 for the period ended March 31, 2024 as compared to Rs. 0.98 for the period ended December 31, 2023.
| Financials | Q4 FY2024 | Q3 FY2024 | % Change |
| Total Income | ₹ 119.3975 crs | ₹97.4049 crs |  22.58% |
| Net Profit | ₹8.0857 crs | ₹4.7846 crs | 68.99% |
| EPS | ₹1.66 | ₹0.98 | 69.39% |
Financial Results (Q4 FY2024) - YoY Comparison
The company has reported total income of Rs. 119.3975 crores during the period ended March 31, 2024 as compared to Rs.106.1050 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.8.0857 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.7.2364 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.1.66 for the period ended March 31, 2024 as compared to Rs.1.48 for the period ended March 31, 2023.
| Financials | Q4 FY2024 | Q4 FY2023 | % Change |
| Total Income | ₹ 119.3975 crs | ₹106.1050 crs | 12.53% |
| Net Profit | ₹8.0857 crs | ₹7.2364 crs | 11.74% |
| EPS | ₹1.66 | ₹1.48 | 12.16% |
Financial Results (Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.372.6083 crores during the Financial Year ended March 31, 2024 as compared to Rs.404.9403 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.17.2464 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.24.4345 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.3.54 for the Financial Year ended March 31, 2024 as compared to Rs.5.01 for the Financial Year ended March 31, 2023.
| Financials | Year Ended FY2024 | Year Ended FY2023 | % Change |
| Total Income | ₹372.6083 crs | ₹404.9403 crs |  -7.98% |
| Net Profit | ₹17.2464 crs | ₹24.4345 crs | -29.42% |
| EPS | ₹3.54 | ₹5.01 | -29.34% |
Shares of Zim Laboratories Ltd was last trading in BSE at Rs. 116.95 as compared to the previous close of Rs. 118.70. The total number of shares traded during the day was 158744 in over 1954 trades.
The stock hit an intraday high of Rs. 117.80 and intraday low of 111.45. The net turnover during the day was Rs. 18053035.00.
